Prostate Cancer Clinical Trials Consortium

This study tests whether the drug talazoparib, given alone or with enzalutamide, can slow cancer growth in men with a specific type of advanced prostate cancer (metastatic castration-resistant) that has certain gene mutations (HRR) and has already progressed after treatment with …

This study is a large international registry that will follow at least 5,000 men with advanced prostate cancer for five years. Researchers will collect information on treatments, side effects, and quality of life to understand what works best in real-world settings. Participants …